ETF Holdings Breakdown of RVMD

RVMD institutional holdings

The adjusted close for RVMD on 2025-11-13 was 64.38

The following institutional investment holdings of RVMD have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-13	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	101,176	USD 6,513,711	64.38
2025-11-13	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	22,474	USD 1,446,876	64.38
2025-11-13	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	121,828	USD 7,843,287 -2.3%	64.38
2025-11-13	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	121,828	USD 7,843,287	64.38
2025-11-13	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	728	USD 46,869	64.38
2025-11-13	IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF)	1,299	USD 83,630	64.38
Total =		369,333	USD 23,777,660

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with RVMD

Revolution Medicines (NASDAQ:RVMD) Earns Buy Rating from Analysts at Truist Financial

Truist Financial assumed coverage on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research note issued to investors on Friday morning, MarketBeat reports. The brokerage issued a buy rating and a $99.00 price target on the stock. RVMD has been the topic of a number of other research reports. Piper Sandler began coverage […] - 2025-09-08 02:04:55

Revolution Medicines (NASDAQ:RVMD) Now Covered by Analysts at Lifesci Capital

Investment analysts at Lifesci Capital began coverage on shares of Revolution Medicines (NASDAQ:RVMD – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $80.00 price target on the stock. Lifesci Capital’s price target would indicate a potential upside of […] - 2025-08-20 02:24:56

Charles Schwab Investment Management Inc. Sells 646 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)

Charles Schwab Investment Management Inc. decreased its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 0.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,930,468 shares of the company’s stock after selling 646 shares during the quarter. Charles Schwab Investment […] - 2025-08-15 05:09:02

KLP Kapitalforvaltning AS Raises Stake in Revolution Medicines, Inc. (NASDAQ:RVMD)

KLP Kapitalforvaltning AS grew its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 17.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,604 shares of the company’s stock after purchasing an additional 4,100 shares during the […] - 2025-07-29 06:16:53

Xponance Inc. Buys 810 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)

Xponance Inc. increased its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 6.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,937 shares of the company’s stock after buying an additional 810 shares during the period. Xponance Inc.’s holdings […] - 2025-07-18 05:01:08

Revolution Medicines, Inc. (NASDAQ:RVMD) Position Trimmed by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lowered its stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 38.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,992 shares of the company’s stock after selling 22,751 shares during the quarter. Allspring Global Investments […] - 2025-07-09 04:42:15

Mirae Asset Global Investments Co. Ltd. Buys 615 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)

Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 11.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 6,221 shares of the company’s stock after acquiring an additional 615 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in […] - 2025-07-07 04:41:58

Guggenheim Reiterates Buy Rating for Revolution Medicines (NASDAQ:RVMD)

Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $80.00 price target on the stock. Guggenheim’s target price points to a potential upside of 113.45% from the stock’s current price. Several other […] - 2025-06-27 02:54:43

Revolution Medicines (NASDAQ:RVMD) Earns “Buy” Rating from Needham & Company LLC

Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $57.00 target price on the stock. Needham & Company LLC’s price target would indicate a potential upside of 48.40% from the company’s […] - 2025-06-26 03:13:04

Harbor Capital Advisors Inc. Takes Position in Revolution Medicines, Inc. (NASDAQ:RVMD)

Harbor Capital Advisors Inc. acquired a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 35,417 shares of the company’s stock, valued at approximately $1,252,000. A number of other hedge funds also recently made […] - 2025-06-13 05:20:59

Analysts Set Revolution Medicines, Inc. (NASDAQ:RVMD) Price Target at $67.08

Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have been given a consensus rating of “Buy” by the twelve ratings firms that are covering the stock, MarketBeat.com reports. Twelve research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have updated their coverage on […] - 2025-06-04 02:36:53

Financial Contrast: Revolution Medicines (NASDAQ:RVMD) & Fate Therapeutics (NASDAQ:FATE)

Fate Therapeutics (NASDAQ:FATE – Get Free Report) and Revolution Medicines (NASDAQ:RVMD – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation. Volatility & Risk Fate Therapeutics has a beta […] - 2025-05-28 02:34:49

Revolution Medicines, Inc. (NASDAQ:RVMD) Shares Bought by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. raised its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 21.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 11,425 shares of the company’s stock after buying an additional 2,041 shares during the period. Envestnet Asset Management Inc.’s holdings in Revolution Medicines were worth $500,000 as […] - 2025-05-05 04:36:57

CANADA LIFE ASSURANCE Co Acquires 545 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)

CANADA LIFE ASSURANCE Co lifted its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 5.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,398 shares of the company’s stock after purchasing an additional 545 shares during the […] - 2025-04-30 05:48:55

Wedbush Reaffirms Outperform Rating for Revolution Medicines (NASDAQ:RVMD)

Wedbush reaffirmed their outperform rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research report report published on Monday,Benzinga reports. They currently have a $67.00 target price on the stock. Other equities analysts have also issued research reports about the stock. UBS Group lifted their price target on shares of Revolution Medicines […] - 2025-04-29 04:42:49

Revolution Medicines, Inc. (NASDAQ:RVMD) Shares Acquired by Sterling Capital Management LLC

Sterling Capital Management LLC increased its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 588.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 1,956 shares of the company’s stock after buying an additional 1,672 shares during the period. Sterling Capital Management LLC’s holdings in Revolution Medicines were worth $86,000 […] - 2025-04-23 05:36:53

Raymond James Financial Inc. Takes Position in Revolution Medicines, Inc. (NASDAQ:RVMD)

Raymond James Financial Inc. acquired a new position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 321,611 shares of the company’s stock, valued at approximately $14,067,000. Raymond James Financial Inc. owned approximately 0.19% of Revolution Medicines […] - 2025-04-22 05:10:59

Needham & Company LLC Reiterates Buy Rating for Revolution Medicines (NASDAQ:RVMD)

Needham & Company LLC reiterated their buy rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research note released on Tuesday,Benzinga reports. The brokerage currently has a $59.00 price objective on the stock. Several other equities analysts have also weighed in on RVMD. Wedbush reissued an “outperform” rating and set a $67.00 […] - 2025-04-11 05:16:58

Revolution Medicines (NASDAQ:RVMD) Hits New 1-Year Low – Time to Sell?

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) hit a new 52-week low during mid-day trading on Saturday . The stock traded as low as $30.94 and last traded at $31.32, with a volume of 2376753 shares. The stock had previously closed at $32.87. Analysts Set New Price Targets A number of brokerages recently issued […] - 2025-04-07 02:40:44

Revolution Medicines (NASDAQ:RVMD) Price Target Lowered to $64.00 at Stifel Nicolaus

Revolution Medicines (NASDAQ:RVMD – Free Report) had its price objective cut by Stifel Nicolaus from $78.00 to $64.00 in a research report released on Tuesday,Benzinga reports. They currently have a buy rating on the stock. Several other research firms have also recently weighed in on RVMD. Guggenheim upped their price objective on Revolution Medicines from […] - 2025-04-02 04:18:58

Revolution Medicines, Inc. (NASDAQ:RVMD) Shares Purchased by Corebridge Financial Inc.

Corebridge Financial Inc. increased its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 2.1% in the 4th quarter, HoldingsChannel reports. The firm owned 83,213 shares of the company’s stock after buying an additional 1,739 shares during the quarter. Corebridge Financial Inc.’s holdings in Revolution Medicines were worth $3,640,000 at the end […] - 2025-03-31 05:22:47

Xponance Inc. Has $530,000 Stock Position in Revolution Medicines, Inc. (NASDAQ:RVMD)

Xponance Inc. raised its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 21.4% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 12,127 shares of the company’s stock after acquiring an additional 2,140 shares during the quarter. Xponance Inc.’s holdings in Revolution Medicines were worth $530,000 at the end of the […] - 2025-03-26 06:24:54

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $66.31 Average Price Target from Analysts

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been assigned a consensus recommendation of “Buy” from the thirteen analysts that are covering the company, MarketBeat Ratings reports. Twelve research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price […] - 2025-03-21 03:20:52

Raymond James Financial Inc. Invests $14.07 Million in Revolution Medicines, Inc. (NASDAQ:RVMD)

Raymond James Financial Inc. bought a new position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 321,611 shares of the company’s stock, valued at approximately $14,067,000. Raymond James Financial […] - 2025-03-19 06:00:47

US Bancorp DE Sells 1,264 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)

US Bancorp DE decreased its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 51.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 1,191 shares of the company’s stock after selling 1,264 shares during the period. US Bancorp DE’s holdings in Revolution Medicines were worth $52,000 at the end of the most recent […] - 2025-03-19 05:10:50

Revolution Medicines, Inc. (NASDAQ:RVMD) Shares Purchased by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. boosted its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 521.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 3,787 shares of the company’s stock after buying an additional 3,178 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Revolution Medicines were worth $165,000 as of its […] - 2025-03-17 06:06:53

Arizona State Retirement System Has $1.48 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD)

Arizona State Retirement System boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 33,905 shares of the company’s stock after buying an additional 650 shares during the quarter. Arizona State Retirement […] - 2025-03-13 05:42:51

Revolution Medicines, Inc. (NASDAQ:RVMD) Position Lowered by Victory Capital Management Inc.

Victory Capital Management Inc. reduced its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 1.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 430,462 shares of the company’s stock after selling 7,288 shares during the quarter. Victory […] - 2025-03-12 05:55:07

Charles Schwab Investment Management Inc. Purchases 167,997 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)

Charles Schwab Investment Management Inc. boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 9.5% during the 4th quarter, Holdings Channel.com reports. The fund owned 1,931,114 shares of the company’s stock after buying an additional 167,997 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Revolution Medicines were worth $84,467,000 […] - 2025-03-11 06:01:13

Amalgamated Bank Buys 435 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)

Amalgamated Bank boosted its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 8.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,707 shares of the company’s stock after acquiring an additional 435 shares during the period. […] - 2025-03-05 07:55:10

Back to Listing

Disclaimer